Drug General Information |
Drug ID |
D0UF0N
|
Former ID |
DIB001459
|
Drug Name |
ACP-319
|
Indication |
Chronic lymphocytic leukaemia [ICD10:C91]
|
Phase 1/2 |
[1]
|
Company |
Acerta pharma
|
Target and Pathway |
Target(s) |
Tyrosine-protein kinase BTK |
Target Info |
Inhibitor |
[2]
|
KEGG Pathway
|
NF-kappa B signaling pathway
|
Osteoclast differentiation
|
Platelet activation
|
B cell receptor signaling pathway
|
Fc epsilon RI signaling pathway
|
Primary immunodeficiency
|
PANTHER Pathway
|
B cell activation
|
Pathway Interaction Database
|
Fc-epsilon receptor I signaling in mast cells
|
BCR signaling pathway
|
FAS (CD95) signaling pathway
|
Class I PI3K signaling events
|
EPO signaling pathway
|
PathWhiz Pathway
|
Fc Epsilon Receptor I Signaling in Mast Cells
|
Reactome
|
MyD88:Mal cascade initiated on plasma membrane
|
Regulation of actin dynamics for phagocytic cup formation
|
DAP12 signaling
|
FCERI mediated Ca+2 mobilization
|
MyD88 deficiency (TLR2/4)
|
IRAK4 deficiency (TLR2/4)
|
RHO GTPases Activate WASPs and WAVEs
|
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
|
WikiPathways
|
Kit receptor signaling pathway
|
MyD88:Mal cascade initiated on plasma membrane
|
Signaling by the B Cell Receptor (BCR)
|
DAP12 interactions
|
B Cell Receptor Signaling Pathway
|
TSLP Signaling Pathway
|
Regulation of toll-like receptor signaling pathway
|
IL-5 Signaling Pathway
|
References |
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800040955) |
---|
REF 2 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1948). |